HaystackAnalytics has launched 'TB One,' a Make-in-India solution aimed at improving TB diagnosis through next-generation sequencing (NGS) in any diagnostic laboratory or hospital.
According to clinical trial results published in The Lancet Haematology, a locally created CAR T-cell immunotherapy has demonstrated a 73% response rate in patients with leukemia and lymphoma, marking a significant achievement for cancer therapy in I
The application of AI in medicine for early diagnoses, and especially cancer prediction, has been acknowledged to be a significant scientific achievement. In India...
Sun Pharmaceutical Industries subsidiary TARO Pharmaceuticals Inc. has completed the 100% acquisition of Antibe Therapeutics Inc., a...
AstraZeneca announced that it has made a deal to take over EsoBiotec, a biotechnology company focused on in vivo cell therapies. EsoBiotec has come up with a new way of using engineered...
Morepen Laboratories Limited has announced the introduction of Empamore, a revolutionary medication for Chronic Kidney Disease (CKD), Heart Failure with Reduced Ejection Fraction (HFrEF), and Type 2 Diabetes Mellitus (T2DM).
By the end of this year, India will commence domestic manufacture of Rifampicin, a first-line anti-tubercular medicine. According to official sources, “Rifampicin is at an advanced stage of execution and is expected to get commissioned later this yea
Chronic Kidney Disease (CKD) is a growing public health crisis in India, affecting a significant percentage of the population and causing over 100,000 new cases of kidney failure annually. Despite its prevalence, early detection remains low, often le
The Apollo Joint Preservation Programme has been launched by Apollo Hospitals, a revolutionary initiative designed to change the face of joint care all over India. This program focuses on...
In a response to allegations that the country's domestic industry has suffered a material injury due to unreasonably low prices at...